Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 65/100

Failure Rate

25.0%

1 terminated/withdrawn out of 4 trials

Success Rate

75.0%

-11.5% vs industry average

Late-Stage Pipeline

25%

1 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 1
2(50.0%)
Phase 4
1(25.0%)
N/A
1(25.0%)
4Total
Phase 1(2)
Phase 4(1)
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT03095547Phase 1Withdrawn

Drug/Drug Interactions With F901318

Role: collaborator

NCT02429024Phase 4Completed

Assessment of SMS and Smartphone Interventions for OneTouch Reveal® Experiences

Role: collaborator

NCT02767336Not ApplicableCompleted

Project BLOOM Regulatory Clinical Evaluation - System Accuracy, User Performance and System Use Evaluation

Role: collaborator

NCT01183208Phase 1Completed

A Safety and Tolerability Study of Administration of PSD502

Role: collaborator

All 4 trials loaded